Ceramides and Phosphatidylcholines Associate with Cardiovascular Diseases in the Elderly
Katajamäki et al. Clin Chem. 2022 Dec 6;68(12):1502-1508.
Lue lisääPlasma ceramides independently predict all-cause mortality in men aged 85
Strandberg et al. Age Ageing. 2022 Jun 1;51(6)
Lue lisääPrior myocardial infarction, coronary artery disease extent, diabetes mellitus, and CERT2 score for risk stratification in stable coronary artery disease
Hilvo et al. European Journal of Preventive Cardiology. Published 28 August 2021
Lue lisääComparison of recent ceramide-based coronary risk prediction scores in cardiovascular disease patients
Leiherer et al. European Journal of Preventive Cardiology. Published: 21 August 2021
Lue lisääAbsolute and relative risk prediction in cardiovascular primary prevention with a modified SCORE chart incorporating ceramide-phospholipid risk score and diabetes mellitus
Hilvo et al. European Heart Journal Open, Published: 13 July 2021
Lue lisääPrimary cardiovascular risk prediction by LDL-cholesterol in Caucasian middle-aged and older adults: a joint analysis of three cohorts
Hilvo et al. European Journal of Preventive Cardiology, Published 01 June 2021
Lue lisääA Novel Two-Lipid Signature Is a Strong and Independent Prognostic Factor in Ovarian Cancer
Salminen et al. Cancers 2021, 13(8), 1764.
Lue lisääPlasma ceramide and phospholipid-based risk score and the risk of cardiovascular death in patients after acute coronary syndrome
Gencer et al. 2020 European Journal of Preventive Cardiology. Published online Dec 2020
Lue lisääCeramides improve atherosclerotic cardiovascular disease risk assessment beyond standard risk factors
Meeusen et al. 2020 Clinica Chimica Acta 511 (2020) 138–142
Lue lisääCeramides and Ceramide Scores: Clinical Applications for Cardiometabolic Risk Stratification
Hilvo et al. 2020. Frontiers in Endocrinology. September 2020 | Volume 11 | Article 570628
Lue lisääAssociations between specific plasma ceramides and severity of coronary-artery stenosis assessed by coronary angiography
Mantovani et al. 2020 Diabetes & Metabolism, 46(2):150-157.
Lue lisääPrediction of Residual Risk by Ceramide‐Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical Therapy
Hilvo et al. 2020 JAHA, Published Online May 2020
Lue lisääDevelopment and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients
Hilvo et al. 2019 Eur Heart J. Published online: 18 June 2019
Lue lisääSusceptibility of low-density lipoprotein particles to aggregate depends on particle lipidome, is modifiable, and associates with future cardiovascular deaths
Ruuth M. et al. 2018 European Heart Journal, 2018: 39 (27),2562–2573.
Lue lisääPlasma concentrations of molecular lipid species predict long-term clinical outcome in coronary artery disease patients
Anroedh et al. 2018 The Journal of Lipid Research. June 1, 2018, doi: 10.1194/jlr.P081281
Lue lisääCeramide stearic to palmitic acid ratio predicts incident diabetes
Hilvo et al. Diabetologia (2018) 61: 1424. https://doi.org/10.1007/s00125-018-4590-6
Lue lisääPCSK9 inhibition alters the lipidome of plasma and lipoprotein fractions
Hilvo et al. 2018 Atherosclerosis Volume 269, Pages 159–165
Lue lisääHigh-grade ovarian serous carcinoma patients exhibit profound alterations in lipid metabolism
Braicu et al. Oncotarget. 2017; 8:102912-102922
Lue lisääCirculating Ceramides Predict Cardiovascular Outcomes in the Population-Based FINRISK 2002 Cohort
Havulinna et al. Arterioscler Thromb Vasc Biol. 2016; 36
Lue lisää